Small cell lung cancer ( SCLC )
Clinical trials for Small cell lung cancer ( SCLC ) explained in plain language.
Never miss a new study
Get alerted when new Small cell lung cancer ( SCLC ) trials appear
Sign up with your email to follow new studies for Small cell lung cancer ( SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo aims to tackle Treatment-Resistant cancers
Disease control Not yet recruitingThis early-stage trial tests whether an experimental drug called TLN-499, combined with the approved cancer drug venetoclax, is safe and tolerable for people with certain advanced solid tumors that have stopped responding to standard treatments. The study includes adults with sma…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase 1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a gentler drug trio tame small cell lung cancer in older patients?
Disease control Not yet recruitingThis trial is testing a combination of three drugs—benmelstobart, anlotinib, and etoposide—as a first treatment for elderly patients (65 and older) or those too frail for standard intensive chemotherapy. The goal is to see if this platinum-free regimen can control the cancer and …
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a 50-Year-Old antipsychotic drug shrink Hard-to-Treat cancers?
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with small cell lung or cervical cancer that has returned after at least two prior treatments. The goal is to see if the drug can shrink tumors or slow disease progression. Participants take the …
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase 1/2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
A deep dive into tumor markers could personalize lung cancer care
Knowledge-focused Not yet recruitingResearchers are collecting blood and tumor tissue samples from 30 adults with relapsed small-cell lung cancer who are receiving a standard DLL3 T cell engager therapy. The goal is to track changes in tumor markers over time and see if those changes relate to how well the treatmen…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC